查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1195586

高级可视化市场——增长、趋势、COVID-19 影响和预测 (2023-2028)

Advanced Visualization Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，高级可视化市场预计将以 11.3% 的复合年增长率增长。

COVID-19 大流行对市场产生了重大影响。 在大流行期间，胸部计算机断层扫描 (CT) 扫描被认为是识别 COVID 感染的最有效的非侵入性方法之一。

主要亮点

  • 波兰放射学杂誌 2022 年 1 月发表的一篇报告显示，COVID-19 肺炎和非 COVID-19 肺炎具有不同的胸部计算机断层扫描 (CT) 特征。我来了。 因此，它是诊断新型冠状病毒病 (COVID-19) 的流行工具。 因此，对高级可视化的需求很高，预计会对市场产生重大影响。 目前，COVID-19病例相对较少，预计COVID-19将导致被调查市场稳步增长。
  • 市场增长的主要驱动因素包括慢性病患病率上升、人口老龄化以及人们越来越意识到先进的可视化工具在疾病诊断中的好处。 根据 Dementia Australia Ltd 在 2022 年发布的一份报告，估计有 487,500 名澳大利亚人患有痴呆症，预计到 2058 年这一数字将增加到约 110 万。 随着人们年龄的增长，痴呆症变得更加普遍。 由于老年人更容易患痴呆症，全球老龄化人口不断增加，市场有望扩大。 因此，痴呆等慢性疾病可以通过放射学检查来诊断，其中先进的可视化技术发挥着重要作用，有望引领市场。
  • 据世界卫生组织称，到 2050 年，全球 60 岁及以上人口将翻一番，达到 21 亿。 随着人口老龄化的加剧，各种慢性病患者的数量预计会增加，先进的可视化工具有望提高患者的正确诊断率。 因此，市场有望实现高增长。
  • 但是，诊断放射学的有限报销可能会限制市场。

高级可视化市场趋势

预计在预测期内肿瘤临床应用将增长

  • 肿瘤学成像主要用于早期检测（例如转移的出现），以阻止或预防全面发展的疾病。 同样，在肿瘤学中，成像对于有效的放射治疗很重要。 因此，图像处理中的高级可视化技术可帮助医生儘早诊断癌症。 推动市场增长的主要因素包括不断提高的技术进步和越来越多地在医疗机构中采用先进的可视化工具。
  • 此外，预计在预测期内，各种类型癌症患病率的上升将推动对高级可视化系统的需求。 根据美国癌症协会“2022 年癌症事实与数据”，到 2040 年，全球癌症负担估计将达到 2800 万新癌症病例，这完全是由于人口增长和老龄化。。 因此，诊断成像的需求不断增长，需要先进的可视化技术来提供准确、高质量的图像。
  • 此外，市场参与者正在向市场推出新产品。 例如，2021 年 11 月，飞利浦在 2021 年北美放射学会 (RSNA) 上推出了新的支持 AI 的 MR7700 3.0T 系统。 它具有最高质量扩散成像和高级神经科学测序的多核临床能力。 因此，考虑到上述所有因素，市场有望在预测期内增长。

预计在预测期内北美将占据重要的市场份额

  • 由于慢性病病例不断增加和医疗保健基础设施的改善，预计北美将在全球高级可视化市场中占据主要市场份额。 此外，老年人口的增加增加了该地区患慢性病的风险，这将推动研究期间的市场增长。
  • 根据加拿大统计局的数据，2021 年和 2022 年 65 岁及以上的人口数量将分别为 7,081,750 和 7,329,910。 同样，阿尔茨海默病协会在 2022 年发布的一份报告估计，2031 年加拿大将有 100 万人患有痴呆症，2050 年将有近 200 万人。 因此，老年人口的增加以及慢性病的增加将增加对诊断成像的需求，其中先进的可视化技术起着关键作用，并且市场有望在预测期内扩大。
  • 此外，在研究期间，高级可视化平台的新进展以及新批准和发布正在推动市场增长。 例如，2021 年 11 月，总部位于圣地亚哥的人工智能和可视化医疗平台 LifeVoxel.AI 筹集了 500 万美元的种子资金。 LifeVoxel 的专利技术能够以零延迟、零客户端足迹即时和无处不在地访问交互式图像研究和数据，并以 4K 质量呈现它们。
  • 因此，由于上述因素，北美市场有望在预测期内实现增长。

高级可见性市场竞争对手分析

高级可视化市场适度整合。 高级可视化市场的市场参与者包括 Agfa-Gevaert Group、Canon Inc.（佳能医疗系统公司）、Carestream Health、Fujifilm Holdings Corporation、通用电气公司（GE Healthcare）、Koninklijke Philips NV、Pro Medicus Ltd、Siemens Healthcare GmbH , 和 Terarecon Inc.

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 慢性病患病率随着老年人口的增加而增加
    • 越来越意识到高级可视化工具在疾病诊断中的优势
  • 市场製约因素
    • 基于辐射的诊断程序的报销限制
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（价值基础，市场规模：100 万美元）

  • 按产品/服务
    • 硬件
    • 软件
    • 按服务
  • 按解决方案类型
    • 企业
    • 独立的
  • 通过成像方式
    • 磁共振成像 (MRI)
    • 计算机断层扫描 (CT)
    • 超声诊断设备
    • 核医学
    • 其他成像方式
  • 通过申请
    • 肿瘤科
    • 骨科
    • 心脏病学
    • 神经
    • 其他临床应用
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Agfa-Gevaert Group
    • Canon Inc.（Canon Medical Systems Corporation）
    • Carestream Health
    • Fujifilm Holdings Corporation
    • General Electric Company（GE Healthcare）
    • Koninklijke Philips NV
    • Pro Medicus Ltd
    • Siemens Healthcare GmbH
    • Terarecon Inc.

第7章 市场机会今后动向

简介目录
Product Code: 57051

The advanced visualization market is expected to register a CAGR of 11.3% over the forecast period. The COVID-19 pandemic had a significant impact on the market. During the pandemic, chest computed tomography (CT) scans were regarded as one of the most effective non-invasive methods for identifying COVID infections.

Key Highlights

  • As per the report published by the Polish Journal of Radiology in January 2022, COVID-19 pneumonia and pneumonia without COVID-19 have different chest computed tomography (CT) characteristics. Hence, it was a commonly used tool for the diagnosis of the novel coronavirus disease (COVID-19). Thus, the demand for advanced visualization was high and expected to impact the market significantly. Currently, the cases of COVID-19 are relatively less, and it is expected to have stable growth in the studied market due to COVID-19.
  • The major factors for the growth of the market include the increasing prevalence of chronic diseases coupled with the growing geriatric population and rising awareness of the benefits associated with advanced visualization tools in disease diagnosis. According to the report published by Dementia Australia Ltd in 2022, an estimated 487,500 Australians are living with dementia, and it is expected to increase to almost 1.1 million by 2058. Dementia is more common as people grow older. The growing geriatric population worldwide is anticipated to increase the market since an aged population is more susceptible to dementia. Hence, chronic diseases like dementia can be diagnosed with radiology, where advanced visualization plays a major role and is expected to drive the market.
  • According to the WHO, by 2050, the world's population of people aged 60 years and older will double to 2.1 billion. The rise in the geriatric population will increase the patient pool suffering from various chronic diseases, and advanced visualization tools are expected to increase the correct diagnosis rate among patients. Hence, the market is expected to witness high growth.
  • However, the limited availability of reimbursements for radiology-based diagnostic procedures may restrain the market.

Advanced Visualization Market Trends

Oncology Under Clinical Application Expected to Grow Over the Forecast Period

  • Imaging in oncology is mostly used for early detection, such as the appearance of metastases, to allow for the interception or prevention of full-blown disease. Similarly, in oncology, imaging is crucial for the effective delivery of radiation treatment. Hence, advanced visualization technology in imaging help physicians to diagnose cancers in the earliest stage possible. The major factors driving the growth of the market include rising technological advancements and an increase in the adoption of advanced visualization tools in healthcare facilities.
  • Furthermore, the rising prevalence of various types of cancer is expected to boost the demand for advanced visualization systems over the forecast period. According to the American Cancer Society, Cancer Facts & Figures 2022, it is estimated that by 2040, the global burden of cancer is expected to reach 28.0 million new cancer cases solely due to the growth and aging of the population. As a result, there is a greater need for diagnostic imaging, which requires sophisticated visualization to provide accurate and high-quality images.
  • Moreover, major market players are launching new products in the market. For instance, in November 2021, Philips launched a new AI-enabled MR 7700 3.0T system in the Radiological Society of North America (RSNA) 2021. It has multinuclear clinical capabilities to deliver the highest quality diffusion imaging and advanced neuroscience sequences. Thus, considering all the above-mentioned factors, the market is expected to grow over the forecast period.

North America Expected to hold a Significant Market Share Over the Forecast Period

  • North America is expected to hold a major market share in the global advanced visualization market due to increasing cases of chronic diseases and the presence of better healthcare infrastructure. Furthermore, the growing geriatric population increases the risk of chronic diseases in the region, which drives the market growth during the study period.
  • According to Statistics Canada, the number of persons aged 65 years and older in 2021 and 2022 is 7,081,750 and 7,329,910, respectively. Similarly, as per the report published by the Alzheimer Society in 2022, it is estimated that by 2031, 1 million people and by 2050, nearly 2 million people in Canada will be living with dementia. Hence the growing geriatric population, along with the rise in chronic diseases, increases the demand for diagnostic imaging where advanced visualization technology plays an important role and thus is expected to grow the market over the forecast period.
  • Moreover, the new advancements, along with the new approvals and launches in advanced visualization platforms, help the market to grow during the study period. For instance, in November 2021, LifeVoxel.AI, a San Diego-based medical platform for AI and Visualization, raised USD 5 million in seed funding. LifeVoxel's patented technologies empower instant and ubiquitous access to interactive imaging studies and data with zero latency and zero client footprint, rendering them at 4K image quality.
  • Thus, owing to the abovementioned factors, the North American segment is expected to grow the market over the forecast period.

Advanced Visualization Market Competitor Analysis

The advanced visualization market is moderately consolidated. Some of the market players in the advanced visualization market are Agfa-Gevaert Group, Canon Inc. (Canon Medical Systems Corporation), Carestream Health, Fujifilm Holdings Corporation, General Electric Company (GE Healthcare), Koninklijke Philips NV, Pro Medicus Ltd, Siemens Healthcare GmbH, and Terarecon Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Chronic Diseases Coupled With Growing Geriatric Population
    • 4.2.2 Rising Awareness of Benefits associated with Advanced Visualization Tools in Disease Diagnosis
  • 4.3 Market Restraints
    • 4.3.1 Limited Availability of Reimbursements for Radiology-Based Diagnostic Procedures
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product and Service
    • 5.1.1 Hardware
    • 5.1.2 Software
    • 5.1.3 Services
  • 5.2 By Type of Solution
    • 5.2.1 Enterprise
    • 5.2.2 Standalone
  • 5.3 By Imaging Modality
    • 5.3.1 Magnetic Resonance Imaging (MRI)
    • 5.3.2 Computed Tomography (CT)
    • 5.3.3 Ultrasound
    • 5.3.4 Nuclear Medicine
    • 5.3.5 Other Imaging Modalities
  • 5.4 By Clinical Application
    • 5.4.1 Oncology
    • 5.4.2 Orthopedics
    • 5.4.3 Cardiovascular
    • 5.4.4 Neurology
    • 5.4.5 Other Clinical Applications
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agfa-Gevaert Group
    • 6.1.2 Canon Inc. (Canon Medical Systems Corporation)
    • 6.1.3 Carestream Health
    • 6.1.4 Fujifilm Holdings Corporation
    • 6.1.5 General Electric Company (GE Healthcare)
    • 6.1.6 Koninklijke Philips NV
    • 6.1.7 Pro Medicus Ltd
    • 6.1.8 Siemens Healthcare GmbH
    • 6.1.9 Terarecon Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS